Filing Details

Accession Number:
0001628280-22-016875
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-10 17:26:41
Reporting Period:
2022-06-08
Accepted Time:
2022-06-10 17:26:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1398733 Aquestive Therapeutics Inc. AQST Pharmaceutical Preparations (2834) 208623253
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406836 Mark Alexander Schobel C/O Aquestive Therapeutics, Inc.,
30 Technology Drive
Warren NJ 07059
Chief Innovation/Tech Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-08 45,871 $0.96 882,871 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (Right to Buy) Acquisiton 2022-06-08 45,871 $0.13 45,871 $0.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,871 2022-12-08 2027-06-08 No 4 P Direct
Footnotes
  1. Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13.